Effect of kidney function and disease status on urinary tissue factor measurements

Journal of Clinical Pathology

Volumn 51, Issue 3, 1998, Pages 234-237

  Lwaleed, B A ^a,c   Bass, P S ^a   Rogerson, M E ^a   Francis, J L ^b   Chisholm, M ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^b FLORIDA HOSPITAL   (United States)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Bacterial growth; Glomerular permeability and filtration; Haematuria; Tubular function; Urinary tissue factor

Indexed keywords

CREATININE; HEMOGLOBIN; N ACETYL BETA GLUCOSAMINIDASE; RETINOL BINDING PROTEIN; THROMBOPLASTIN;

ARTICLE; BACTERIAL GROWTH; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ACTIVITY; GLOMERULUS FILTRATION; HEMATURIA; HUMAN; HYPERTENSION; INTERSTITIAL NEPHRITIS; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; NEPHROTIC SYNDROME; PRIORITY JOURNAL; URINALYSIS;

EID: 0031955416     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.51.3.234     Document Type: Article

References (40)

1. Grunke W. Studien über die Bluterinnung mit besonderer Berücksichtigung der Haemophilie. I. Mitteilung: Einfluss des Harnes auf die Gerinnung haemophilen Blutes. Blutes Z Ges Exp Med 1835;96:512-16.
2. Tocantins LM, Lindquist JN. Thromboplastic activity of the urine. Proc Soc Exp Biol NY 1947;65:44-9.
3. von Kaulla KN. Extraction and concentration of thromboplastic material from human urine. Proc Soc Exp Biol Med NY 1956;91:543-5.
4. Matsumura T, Hutt MP, von Kulla KN. Urinary procoagulant excretion and its relation to kidney function. Nephron 1970;7:165-77.
5. Caldwell J, von Kulla KN, von Kulla E, et al. Procoagulant material from human urine in prothrombin activation. Thromb Diath Haemorrh 1963;61:53-61.
6. Kurosawa S, Matsuda M, Aoki N. Urinary procoagulant behaves as tissue factor by promoting factor VIIa-catalyzed activation of factor X. Thromb Res 1984;33:595-606.
7. Wiggins R, Glatfelter A, Kshirsagar B, et al. Lipid vesicles and their association with procoagulant activity and glomeruli of rabbits with nephrotoxic nephritis. Lab Invest 1987;56:264-72.
8. Zacharski LR, Rosenstein R, Phillips PG. Concanavalin A inhibition of tissue factor (thromboplastin) activity. Blood 1974;44:783-7.
9. Carty N, Taylor I, Roath OS, et al. Urinary tissue factor activity in malignancy. Thromb Res 1990;57:473-8.
10. Bach RR, Nemrson Y, Konigsberg WK. Purification and characterization of bovine tissue factor. J Biol Chem 1981; 256:8324-31.
11. Guha A, Bach RR, Konigsberg W, et al. Affinity purification of human tissue factor. Interaction of factor VII and tissue factor in detergents micelles. Proc Natl Acad Sci USA 1986; 83:299-302.
12. Nemerson Y, Bach R. Tissue factor revisited. Prog Hemost Thromb 1982;6:237-61.
13. Nemerson Y. The tissue factor pathway of blood coagulation. Semin Haemost 1992;29:170-6.
14. Osterud B, Rapaport S. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 1977;74:5260-4.
15. Wada H, Wakita Y, Shiku H. Tissue factor expression in endothelial cells in health and disease. Blood Coag Fibrinol 1995;6:26-31.
16. Fareed J, Callas DD, Hoppensteadt D, et al. Tissue factor antigen levels in various biological fluids. Blood Coag Fibrinol 1995;6:32-6.
17. Drake TA, Rogers GM, Sande MA. Tissue factor is a major stimulus for vegetation formation in enterococcal endocarditis in rabbits. J Clin Invest 1984;73:1750-3.
18. Prydz H. Synthesis and surface availability of thromboplastin and plasminogen activator in mononuclear phagocytes. In: Mononuclear phagocytes: physiology and pathology. Dean, RT, Jessup, W, eds. New York: Elsevier, 1985:115-37.
19. Francis JL. Haemostasis and cancer. Med Lab Sci 1989;46: 331-46.
20. Folkman J. Tumour angiogenesis and tissue factor. Nat Med 1996;2:167-8.
21. Lwaleed BA, Francis JL, Chisholm M. Urinary tissue factor level in neoplastic diseases [abstract]. Br J Haematol 1996; 27:103.
22. Lwaleed BA, Bass PS, Chisholm M, et al. Urinary tissue factor levels in glomerulonephritis: a potential marker of glomerular injury? J Clin Pathol 1997;50:336-40.
23. Watanabe K, Kamei S, Ohkubo A, et al. Urinary protein as measured with a pyrogallo red-molybdate complex. Manually and in a Hitachi 726 automated analyzer. Clin Chem 1986;32:1551-4.
24. Orsonneau J, Douet P, Massoubre C, et al. An improved pyrogallol red-molybdate method of determining total urinary protein. Clin Chem 1989;35:2233-6.
25. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
26. Waller DG, Keast CM, Fleming SJ, et al. Measurement of glomerular filtration rate with technetium-99m DTPA: comparison of plasma clearance techniques. J Nucl Med 1987;28:372-7.
27. Rowe DJF, Anthony F, Polak A, et al. Retinol binding protein as a small molecular weight marker of renal tubular function in diabetes mellitus. Ann Clin Biochem 1987;24: 477-82.
28. Yuen CT, Price RG, Chattagoon L, et al. Colorimetric assays for N-acetyl-β-D-glucosaminidase and β-D-galactosidase in human urine using newly-developed w-nitrostyryl substrates. Clin Chem Acta 1982;124:195-204.
29. Twyman SJ, Rowe DJ. A sensitive radio-immunoassay for the determination of haemoglobin in urine. Ann Clin Biochem 1995;32:506-8.
30. Smith SA. Estimation of glomerular filtration rate from the serum creatinine. Postgrad Med J 1988;64:204-8.
31. Waller DG, Fleming JS, Ramsay B, et al. The accuracy of creatinine clearance with and without urine collection as a measure of glomerular filtration rate. Postgrad Med J 1991; 67:42-6.
32. Daugaard G, Rossing N, Rorth M. Effects of cisplatin on different measures of glomerular function in the human kidney with special emphasis on high-dose. Cancer Chemother Pharmacol 1988;21:163-7.
33. Brochner-Mortensen J, Rodbro P. Selection of routine method for determination of glomerular filtration rate in adults. Scand J Clin Lab Invest 1976;36:35-43.
34. Matsumura T, von Kaulla KN. Procoagulant content of human urine in health and disease. Am J Clin Pathol 1968; 50:198-210.
35. Matsumura T, Hutt MP, von Kulla KN. Urinary procoagulant excretion in experimental renal disease. Proc Soc Exp Biol Med 1968;127:147-53.
36. Matsuda M, Aoki N, Kawaoi A. Localization of urinary procoagulant in human kidney. Kidney Int 1979;15:612-17.
37. Adamson AS, Francis JL, Roath OS, et al. Urinary tissue factor levels in transitional cell carcinoma of the bladder. J Urol 1992;148:449-52.
38. Osterud B, Flaegstad T. Increased thromboplastin activity in monocytes of patients with meningococcal infection: related to an unfavourable prognosis. Thromb Haemost 1983;49:5-7.
39. Wellwood JM, Price RG, Ellis BG, et al. A note on the practical aspects of the assay of N-acetyl-β-glucosaminidase in human urine. Clin Chim Acta 1976;69:85-91.
40. 2-microglobulin determination in urine for the early detection of tubular proteinuria. Clin Chim Acta 1982;126:1-7.